News & Updates
Filter by Specialty:
Show Multimedia Only
Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication
08 Nov 2024
Vonoprazan-based bismuth-containing quadruple therapy (VBCQ) does better at eradicating Helicobacter pylori (H. pylori) than proton pump inhibitor (PPI)-based BCQ therapy (PBCQ), with similar adverse reactions and compliance, a study has shown.
Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication
08 Nov 2024
Menopausal hormone therapy prevents relapse in women with SSD
07 Nov 2024
Use of menopausal hormone therapy (MHT) can avert psychosis relapse in women with schizophrenia or schizoaffective disorder (SSD) of menopausal age, suggests a recent study.
Menopausal hormone therapy prevents relapse in women with SSD
07 Nov 2024
Pegaspargase biosimilar safe to use in childhood ALL
05 Nov 2024
The biosimilar Pegaspargase, when combined with chemotherapy, demonstrates a favourable safety profile in children with acute lymphoid leukemia (ALL) treated according to ICiCLe ALL-14 protocol, a study has shown.